1. 1The paper's authors are all members of the Pharmacogenetics Working Group (PWG). See http://www.pharmacogeneticsworkinggroup.org. The companies whose representatives participated in the preparation of this paper are: Abbott Laboratories, Amgen, AstraZeneca, Aventis, Biogen Idec, Bristol-Myers Squibb, Eisai, Eli Lilly and Company, GlaxoSmithKline, Hoffmann La-Roche, Johnson & Johnson, Merck, Sharpe & Dohme, Millennium, Novartis, Organon, Orion, Pfizer, Sanofi-Synthelabo, Schering AG, Schering-Plough, Teva Pharmaceutical Industries and Wyeth.
2. Pharmacogenetics and disease genetics of complex diseases
3. Pharmacogenomic considerations in drug delivery
4. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment